The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis

Devonshire, Virginia; Lapierre, Yves; Macdonell, R.; Ramo‐Tello, C.; Patti, Francesco; Fontoura, Paulo; Suchet, Laurent; Hyde, Robert; Balla, I.; M. Frohman, Elliot; C. Kieseier, B.; the GAP Study Group, for

doi:10.1111/j.1468-1331.2010.03110.x

Public

The Global Adherence Project (GAP): a multicenter observational study on adherence to disease‐modifying therapies in patients with relapsing‐remitting multiple sclerosis

Published in European Journal of Neurology • Jun 15, 2010

Authors:

Virginia Devonshire

Yves Lapierre

R. Macdonell

Abstract

BACKGROUND: most disease-modifying therapies (DMTs) for multiple sclerosis (MS) are self-injectable medications that must be taken on an ongoing basis to reduce disease activity. Thus, adherence to therapy becomes an important challenge that must be addressed to maximize benefits of therapy. This st...

Subject

Medicine

Glatiramer acetate

Observational study

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!